DE69303413D1 - 2-substituierte-tertiäre-Carbinolderivate als antivirale Arzneimittel - Google Patents

2-substituierte-tertiäre-Carbinolderivate als antivirale Arzneimittel

Info

Publication number
DE69303413D1
DE69303413D1 DE69303413T DE69303413T DE69303413D1 DE 69303413 D1 DE69303413 D1 DE 69303413D1 DE 69303413 T DE69303413 T DE 69303413T DE 69303413 T DE69303413 T DE 69303413T DE 69303413 D1 DE69303413 D1 DE 69303413D1
Authority
DE
Germany
Prior art keywords
tertiary
substituted
antiviral drugs
carbinol derivatives
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69303413T
Other languages
English (en)
Other versions
DE69303413T2 (de
Inventor
Ish Kumar Khanna
Richard August Mueller
Richard Mathias Weier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Application granted granted Critical
Publication of DE69303413D1 publication Critical patent/DE69303413D1/de
Publication of DE69303413T2 publication Critical patent/DE69303413T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
DE69303413T 1992-04-01 1993-03-31 2-substituierte-tertiäre-Carbinolderivate als antivirale Arzneimittel Expired - Fee Related DE69303413T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/861,058 US5258518A (en) 1992-04-01 1992-04-01 2-substituted tertiary carbinol derivatives of deoxynojirimycin

Publications (2)

Publication Number Publication Date
DE69303413D1 true DE69303413D1 (de) 1996-08-08
DE69303413T2 DE69303413T2 (de) 1997-01-09

Family

ID=25334759

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69303413T Expired - Fee Related DE69303413T2 (de) 1992-04-01 1993-03-31 2-substituierte-tertiäre-Carbinolderivate als antivirale Arzneimittel

Country Status (9)

Country Link
US (7) US5258518A (de)
EP (1) EP0566556B1 (de)
JP (1) JP3210772B2 (de)
AT (1) ATE139998T1 (de)
CA (1) CA2093078C (de)
DE (1) DE69303413T2 (de)
DK (1) DK0566556T3 (de)
ES (1) ES2090948T3 (de)
GR (1) GR3021228T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5451679A (en) * 1994-03-08 1995-09-19 G. D. Searle & Co. 2-chloro and 2-bromo derivatives of 1,5-iminosugars
DK0817775T3 (da) * 1995-03-30 2001-11-19 Pfizer Quinazolinderivater
US5840711A (en) * 1995-06-21 1998-11-24 University Of Kentucky Research Foundation Compositions containing lithium inorganic salts and anti-viral drugs and method of treating viral infections such as acquired immunodeficiency syndrome
US20030100532A1 (en) 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
DE69821520T2 (de) * 1997-11-10 2004-12-16 G.D. Searle & Co., Chicago Verwendung von alkylierten iminozuckern zur behandlung von multipler medikamentenresistenz
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
ATE331515T1 (de) 1998-02-12 2006-07-15 Searle Llc Verwendung von n-substituirten-1,5-dideoxy-1,5- imino-d-glucitolen zur behandlung von hepatitis infektionen
EP1173161A2 (de) 1999-02-12 2002-01-23 G.D. SEARLE & CO. Verwendung von glucamin derivaten zur behandlung von hepatitis infektionen
DE60039729D1 (de) 1999-02-12 2008-09-11 United Therapeutics Corp N-(8,8,8-Trifluorooctyl)-1,5-dideoxy-1,5-imino-D-glucitol zur Behandlung von Hepatitis-Virus-Infektionen
EP2027137B1 (de) * 2005-06-08 2015-02-18 Amicus Therapeutics, Inc. Aufreinigung von imino- und aminozuckern
BRPI0613221A2 (pt) * 2005-06-08 2010-12-28 Amicus Therapeutics Inc furanose cristalina e método para produzir uma furanose cristalina
EP1888610A1 (de) * 2005-06-08 2008-02-20 Amicus Therapeutics, Inc. Stabilisierung von mit triflatgruppen versehenen verbindungen
JP6166150B2 (ja) * 2013-10-29 2017-07-19 アルプス電気株式会社 受光装置
EP3318277A1 (de) 2016-11-04 2018-05-09 Institut du Cerveau et de la Moelle Epiniere-ICM Inhibitoren der glucosylceramidsynthase zur behandlung von motoneuronerkrankungen

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
GB2020278B (en) * 1978-05-03 1983-02-23 Nippon Shinyaku Co Ltd Moranoline dervitives
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
DE2848117A1 (de) * 1978-11-06 1980-05-14 Bayer Ag Derivate des 2-hydroxymethyl-3,4,5- trihydroxy-piperidins, ihre herstellung und verwendung zur beeinflussung des kohlenhydrat- und fettstoffwechsels
DE3007078A1 (de) * 1980-02-26 1981-09-10 Bayer Ag, 5090 Leverkusen Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung
US4632992A (en) * 1981-02-09 1986-12-30 Pfizer Inc. Intermediates for preparing pirbuterol and analogs
DE3620645A1 (de) * 1985-12-20 1987-07-02 Bayer Ag 3-amino-4,5-dihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung
ATE126696T1 (de) * 1985-12-23 1995-09-15 Hutchinson Fred Cancer Res Regulierung der retroviralen replikation, infektion und pathogenese.
DE3611841A1 (de) * 1986-04-09 1987-10-15 Bayer Ag Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten
EP0282618A1 (de) * 1987-03-18 1988-09-21 Vereniging Het Nederlands Kanker Instituut 1-Deoxynojirimycin als Anti-HIV-Therapeutikum
JPS6461459A (en) * 1987-08-28 1989-03-08 Nippon Shinyaku Co Ltd Moranoline derivative
US4999360A (en) * 1987-12-21 1991-03-12 Monsanto Company Method of inhibiting virus
US4849430A (en) * 1988-03-09 1989-07-18 Monsanto Company Method of inhibiting virus
US4861892A (en) * 1988-02-12 1989-08-29 G. D. Searle & Co. Method for synthesis of deoxymannojirimycin
US5144037A (en) * 1988-11-03 1992-09-01 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-d-glucitol derivatives
US5003072A (en) * 1988-11-03 1991-03-26 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-D-glucitol derivatives
US4957926A (en) * 1988-12-22 1990-09-18 Monsanto Company Method of treating herpesviruses
US5011829A (en) * 1989-06-02 1991-04-30 G. D. Searle & Co. Pharmaceutical composition and method of inhibiting virus
US5175168A (en) * 1989-07-27 1992-12-29 Monsanto Company Intermediates for 1,2-dideoxy-2-fluoronojirimycin
US5026713A (en) * 1989-08-29 1991-06-25 Monsanto Company 1,3-dideoxy-3-fluoronojirimycin which inhibits glycosidase activity
US5025021A (en) * 1989-07-27 1991-06-18 Monsanto Company 1,2-dideoxy-2-fluoronojirimycin as glycosidase inhibitors
ES2036512T3 (es) * 1989-07-27 1996-03-01 Monsanto Co Compuestos de piperidina con actividad inhibidora de las glicosidasas.
US5218121A (en) * 1989-08-29 1993-06-08 Monsanto Company Synthesis of 1,3-dideoxy-3-fluoronojirimycin
US5130320A (en) * 1989-08-29 1992-07-14 Monsanto Company Glycosidase inhibiting 1,3-dideoxy-3-fluoronojirimycin
US5030638A (en) * 1990-02-26 1991-07-09 G. D. Searle & Co. Method of antiviral enhancement
DE4009561A1 (de) * 1990-03-24 1991-09-26 Bayer Ag Neue desoxynojirimycinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5273981A (en) * 1990-10-18 1993-12-28 Monsanto Company Intramolecular carbamate derivative of 2,3-Di-O-blocked-1,4-dideoxy-4-fluoro-nojirimycins
US5128347A (en) * 1990-10-18 1992-07-07 Monsanto Company Glycosidase inhibiting 1,4-dideoxy-4-fluoronojirimycin
US5216168A (en) * 1992-04-01 1993-06-01 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5331096A (en) * 1992-04-01 1994-07-19 G. D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
US5206251A (en) * 1992-04-01 1993-04-27 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars

Also Published As

Publication number Publication date
ES2090948T3 (es) 1996-10-16
JPH06279408A (ja) 1994-10-04
DE69303413T2 (de) 1997-01-09
CA2093078C (en) 2005-02-22
US5530132A (en) 1996-06-25
DK0566556T3 (da) 1996-08-19
EP0566556A1 (de) 1993-10-20
US5637707A (en) 1997-06-10
EP0566556B1 (de) 1996-07-03
US5258518A (en) 1993-11-02
US5502193A (en) 1996-03-26
GR3021228T3 (en) 1997-01-31
US5350854A (en) 1994-09-27
ATE139998T1 (de) 1996-07-15
JP3210772B2 (ja) 2001-09-17
US5523406A (en) 1996-06-04
CA2093078A1 (en) 1993-10-02
US5639882A (en) 1997-06-17

Similar Documents

Publication Publication Date Title
DE69303413T2 (de) 2-substituierte-tertiäre-Carbinolderivate als antivirale Arzneimittel
ATE88998T1 (de) Benzodiazepin-derivate und diese enthaltende arzneimittel.
ATE183182T1 (de) S-triazinderivate als lichtschutzmittel
DE69326369T2 (de) 14-Beta-Hydroxy-10-Deacetyl-Baccatin-III und seine Derivate als Antitumormittel
ATE119774T1 (de) Imidazopyridinderivate und ihre verwendung.
IE891379L (en) Benzopyrido piperidine, piperidylidene and piperazine¹compounds
NO931482D0 (no) Farmasoeytiske sammensetninger inneholdende quinolin- og quinazolinderivater og nye forbindelser for disse
DE69016571D1 (de) 1,4-Dideoxy-1,4-imino-D-mannitol-Derivate.
DE68916174T2 (de) Mevalonolactone vom Thienopyridin-Typ.
ATE153657T1 (de) Cyclische benzylamino-, benzylamido- und benzylimido derivate als antipsychotische wirkstoffe
DK0736009T3 (da) N-oxider af 4-arylpiperaziner og 4-arylpiperidiner som antipsykotiske medikamenter
DE69304393D1 (de) 2- und 3-Amino und Azidoderivate von 1,5-Iminozuckern als antivirale Arzneimittel
AU4843093A (en) Anti-viral sulfur-analogues of 1,5-dideoxy-1,5-imino-d-glucitol (deoxynojirimycin)
DK656889D0 (da) Hidtil ukendte forbindelser
DK0587048T3 (da) Heteroarenylpiperaziner, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
DK0527298T3 (da) Fremgangsmåde til fremstilling af pipazetate
ES2141228T3 (es) Derivados del benzopirano.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee